Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
01/02/2002 | EP0808310B1 3-(4-cyanophenyl)uracils |
01/02/2002 | EP0706518B1 Acylated aminophenyl urea compounds, their preparation and their use as herbicides and plant-growth regulators |
01/02/2002 | CN1329493A Methods and compositions for restoring conformational stability of a protein of the p53 family |
01/02/2002 | CN1329491A Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
01/02/2002 | CN1328824A Compound for curing female sexual disorder |
01/01/2002 | US6335460 Treating retroviral infections, including human immunodeficiency virus, and aids |
01/01/2002 | US6335445 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
01/01/2002 | US6335367 Fungicidal and insecticidal benzyloxy cyclopropyl substituted aromatic compounds |
01/01/2002 | US6335356 Method of treating a patient by parenteral administration of a lipophilic compound |
01/01/2002 | US6335344 Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases |
01/01/2002 | US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis |
01/01/2002 | US6335332 Barbituric acid derivatives with antimetastatic and antitumor activity |
01/01/2002 | CA2024156C Compositions for use in controling the shedding of hair and in the induction and stimulation of its growth, such compositions containing 2-amino pyrimidine 3-oxide derivatives andnovel 2-amino pyrimidine 3-oxide derivative compounds |
12/27/2001 | WO2001098522A2 Positively-charged peptide nucleic acid analogs with improved properties |
12/27/2001 | WO2001098304A1 A process for preparing pyrazolopyrimidinone derivatives for the treatment of impotence |
12/27/2001 | WO2001098278A1 Methods and compositions utilizing quinazolinones |
12/27/2001 | WO2001098277A2 Substituted bicyclic derivatives for the treatment of abnormal cell growth |
12/27/2001 | WO2001098251A1 Novel substituted nitrocatechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
12/27/2001 | WO2001097751A2 New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
12/27/2001 | CA2413556A1 Positively-charged peptide nucleic acid analogs with improved properties |
12/27/2001 | CA2411100A1 New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
12/26/2001 | CN1328561A Pyrimidin-4-enamine as fungicide |
12/26/2001 | CN1328466A Use of antifungal agents for treating scleroses |
12/25/2001 | US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation |
12/25/2001 | US6333331 Useful in inactivating the human dna repair protein o.sup.6 -alkylguanine-dna alkyltransferase; anticancer agents |
12/25/2001 | US6333296 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them |
12/25/2001 | US6333082 Liquid crystalline (E,E)-butadiene compounds and mixtures and devices containing such compounds |
12/25/2001 | US6333080 High anisotropy, high elastic constant ratio, excellent comparability with other liquid-crystal compounds, and low viscosity and are chemically and physically stable |
12/25/2001 | CA2037733C Trifluoro- and chlorodifluoromethoxypyrimidines and the preparation thereof |
12/21/2001 | CA2351129A1 Novel substituted nitrocatechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
12/20/2001 | WO2001096353A2 3'-PRODRUGS OF 2'-DEOXY-β-L-NUCLEOSIDES |
12/20/2001 | WO2001096327A1 BIOISOSTERIC BENZAMIDE DERIVATIVES AND THEIR USE AS APoB-100 SECRETION INHIBITORS |
12/20/2001 | WO2001096318A1 Cyclic urea compounds and preparation thereof |
12/20/2001 | WO2001096314A1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines |
12/20/2001 | WO2001096310A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists |
12/20/2001 | WO2001074788A8 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
12/20/2001 | WO2001016108A3 Bicyclic androgen and progesterone receptor modulator compounds and methods |
12/20/2001 | WO1999019304A3 Alpha-alkylthio substituted pyrimidine ethers and thioethers as viral reverse transcriptase inhibitors |
12/20/2001 | US20010053853 Alkanoic acid derivative; integrin receptor antagonist |
12/20/2001 | US20010052500 Adding a chelating agent continuously to a semiconductor manufacturing process waste stream containing a metal residue to form a metal complex with at least a portion of the metal residue, and removing the metal complex |
12/20/2001 | CA2778314A1 Cyclic urea compounds and preparation thereof |
12/20/2001 | CA2412010A1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines |
12/19/2001 | EP1163238A1 Chemokine recpetor binding heterocyclic compounds |
12/19/2001 | EP1163237A1 Amide derivatives |
12/19/2001 | EP1163228A1 Quinazolines and therapeutic use thereof |
12/19/2001 | EP1163227A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them |
12/19/2001 | EP1163221A1 Sulfonamide derivatives as 5ht7 receptor antagonists |
12/19/2001 | EP1163214A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
12/19/2001 | EP1162974A1 Quinazoline formulations and therapeutic use thereof |
12/19/2001 | EP1094816A4 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
12/19/2001 | EP0971902B1 Aminosulfonylureas with herbicidal activity |
12/19/2001 | EP0885198B1 4-anilinoquinazoline derivatives |
12/19/2001 | EP0711270B1 Polymers comprising 4-substituted cyclohexane units |
12/18/2001 | USRE37478 1-(arylthioalkyl, arylaminoalkyl, or arylmethylenealkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics |
12/18/2001 | US6331640 Diaminopropionic acid derivatives |
12/18/2001 | US6331629 Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines; dopamine receptor subtype specific ligands |
12/18/2001 | US6331628 Reacting a substituted halobenzene with potassium, sodium and/or zinc cyanide in the presence of a metallic catalyst |
12/18/2001 | US6331627 Intermediates of benzoxazinone derivatives and preparation thereof |
12/18/2001 | US6331563 N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl, Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase inhibitors |
12/18/2001 | US6331553 Inhibitors of nitric oxide synthase; treating cerebrovascular diseases |
12/18/2001 | US6331546 Use of 2-amino-3,4-dihydroquinazolines for the production of a medicament for the treatment or prophylaxis of illnesses caused by ischemic conditions |
12/18/2001 | US6331538 Treatment of bacterial infection |
12/18/2001 | US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
12/18/2001 | CA2085589C Benzoquinazoline compounds |
12/13/2001 | WO2001094350A1 6-phenylpyrrolopyrimidinedione derivatives |
12/13/2001 | WO2001094341A1 Quinazoline derivatives for the treatment of tumours |
12/13/2001 | WO2001094320A2 Process to prepare sulfonamides |
12/13/2001 | WO2001094299A1 Benzene derivatives |
12/13/2001 | WO2001093841A2 Barbituric acid analogs as therapeutic agents |
12/13/2001 | WO2001044200A3 Selective neurokinin antagonists |
12/13/2001 | US20010051721 Hydrated forms of lopinavir; HIV protease inhibitor |
12/13/2001 | US20010051633 E.g.,N-((4-amino-3-nitrophenoxy)ethyl)-1,2,3,4-tetrahydro -isoquinoline; stroke; antiischemic agents; CNS trauma, hyperglycemic agents; surgery; neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis |
12/13/2001 | US20010051629 Lipid lowering quinazoline dietary supplement composition |
12/13/2001 | US20010051139 Therapy for skin disorders |
12/13/2001 | DE10101324C1 New 1-(dimercaptoalkyl)-quinazoline-2,4(1H,3H)-diones, are stable matrix metalloproteinase inhibitors useful e.g. for treating rheumatism, tumor metastasis or sunburn |
12/13/2001 | DE10002835C1 Production of 4-methylpyridine, useful as an intermediate for pharmaceuticals and plant protection agents, comprises reacting a 4,4-dialkoxy-2-butanone with a formamidine salt |
12/13/2001 | CA2411013A1 6-phenylpyrrolopyrimidinedione derivatives |
12/12/2001 | EP1161428A1 Pyrimidine compounds |
12/12/2001 | EP1161415A2 N-cyanomethylamides as protease inhibitors |
12/12/2001 | EP1161280A1 Use of an integrin antagonist and a chemotherapeutic agent in the treatment of neoplasia |
12/12/2001 | EP0820436B1 Substituted cycloalkenes and their use as microbicides, especially as fungicides |
12/12/2001 | EP0781276B1 Pyrimidinone derivatives |
12/12/2001 | CN1326494A Chiral liquid crystal compounds having fluorinated terminal portion |
12/12/2001 | CN1326453A Novel poyrimidine derivatives and process for preparation thereof |
12/12/2001 | CN1326114A Image element containing closed compounds for taking pictures |
12/12/2001 | CN1076020C Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation method and compositions |
12/12/2001 | CN1076019C Preparation of triazoles by organometallic addition to ketonts and intermediates therefor |
12/11/2001 | US6329360 Hetero-linked phenylglycinolamides |
12/11/2001 | US6329323 Aminosulfonylureas with herbicidal activity |
12/11/2001 | CA2203011C Herbicidal sulfonyl urea derivatives |
12/11/2001 | CA1341325C Triazole antifungal agents |
12/06/2001 | WO2001092263A1 Novel triazolo pyrimidine compounds |
12/06/2001 | WO2001023362A3 Rate-controlled particles |
12/06/2001 | WO2001019800A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
12/06/2001 | US20010049374 Amidino derivatives of quinoline and naphthalene |
12/06/2001 | DE10108447A1 Nematic liquid crystal displays, useful in low- and medium-multiplexed devices, contain specific cyanopyridine and bicyclohexyl derivatives with e.g. very fast switching time |
12/05/2001 | EP1160331A1 Enzymatic oxidations |
12/05/2001 | EP1160243A1 Process for producing quinazoline derivative or salt thereof |
12/05/2001 | EP1160242A1 Aromatic fatty acid esters |
12/05/2001 | EP1159271A1 Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof |